The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Ironwood Pharmaceuticals Inc

Nasdaq: IRWD
Last

(U.S.) $15.66

Today's change-0.22 -1.39%
Updated September 29 10:35 AM EDT. Delayed by at least 15 minutes.
 

Ironwood Pharmaceuticals Inc

Nasdaq: IRWD
Last

(U.S.) $15.66

Today's change-0.22 -1.39%
Updated September 29 10:35 AM EDT. Delayed by at least 15 minutes.

Reversal following new 52-week high

Ironwood Pharmaceuticals Inc is lower today, dropping (U.S.)$0.22 or 1.39% to (U.S.)$15.66 after setting a new 52-week high. Shares have lost 1.32% over the last five days, but sit 3.12% below their 52-week high. This security has outperformed the S&P 500 by 44.08% during the last year.

Key company metrics

  • Open(U.S.) $15.83
  • Previous close(U.S.) $15.88
  • High(U.S.) $15.83
  • Low(U.S.) $15.60
  • Bid / Ask(U.S.) $15.66 / (U.S.) $15.67
  • YTD % change+35.12%
  • Volume152,408
  • Average volume (10-day)1,470,180
  • Average volume (1-month)1,123,757
  • Average volume (3-month)1,169,040
  • 52-week range(U.S.) $7.35 to (U.S.) $16.17
  • Beta1.52
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.67
Updated September 29 10:35 AM EDT. Delayed by at least 15 minutes.

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue54665340
Total other revenue--------
Total revenue54665340
Gross profit54665340
Total cost of revenue0000
Total operating expense70685966
Selling / general / administrative37363230
Research & development32322826
Depreciation / amortization1------
Interest expense (income), net operating--------
Unusual expense (income)0--09
Other operating expenses, total--------
Operating income-15-2-6-26
Interest income (expense), net non-operating-10-10-10-10
Gain (loss) on sale of assets--------
Other--------
Income before tax-22-13-14-47
Income after tax-22-13-14-47
Income tax, total--------
Net income-22-13-14-47
Total adjustments to net income--------
Net income before extra. items-22-13-14-47
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-22-13-14-47
Inc. avail. to common incl. extra. items-22-13-14-47
Diluted net income-22-13-14-47
Dilution adjustment------0
Diluted weighted average shares145144143142
Diluted EPS excluding extraordinary itemsvalue per share-0.15-0.09-0.10-0.33
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.15-0.09-0.10-0.27